Golden
Cognition Therapeutics

Cognition Therapeutics

Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.

Cognition Therapeutics is a biotechnology and pharmaceutical company that was founded by Gilbert Rishton and Susan Catalano in 2007, and is headquartered in Pittsburgh, Pennsylvania. Cognition Therapeutics engages in drug development and discovery to develop novel approaches to the treatment of central nervous system disorders. The companies treatment approach to central nervous system disorders, such as Alzheimers disease and other neurodegenerative disorders, is to prevent the accumulation of toxic proteins associated with central nervous system disorders through the discovery and application of small molecule drug therapies.

Timeline

People

Name
Role
Related Golden topics

Alexander Craig

Investor

Alicia Syrett

Investor

Anne Estabrook

Investor

David Hunt/Hunt Technology Ventures, L.P.

Investor

Deb Gerardi Kemper

Investor

Elinor MacKinnon

Investor

Gilbert Rishton

Chief Medicinal Chemistry Advisor

Hank Safferstein

Senior Vice President

Hans Hugh Miller

Investor

Jacqueline Dedell

Investor

Jean Peters

Investor

Jenevra Georgini

Investor

John B Goodrich

Investor

Kat Dave

Investor

Kenneth Moch

President & CEO

Marc Brands

Investor

Marcia Rick Dawood

Investor

Marjorie Kaufman, CFA

Investor

Michael Grundman

Chief Medical Advisor

Robert Windsor

Investor

Squirrel Hill Ventures

Investor

Stephen DiPalma

Chief Financial Officer

Susan Catalano

Founder & Chief Science Officer

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References